Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Occidental Petroleum
OXY
5
Louisiana-Pacific
LPX
CN Stock MarketDetailed Quotes
002370 Zhejiang Yatai Pharmaceutical
- 3.17
- 0.000.00%
Market Closed May 12 15:00 CST
2.36BMarket Cap81.28P/E (TTM)
3.22High3.14Low193.15KlotVolume3.20Open3.17Pre Close61.17MTurnover2.59%Turnover Ratio68.91P/E (Static)745.67MShares4.3852wk High2.49P/B2.36BFloat Cap2.2152wk Low3.49Limit Up745.67MShs Float22.10Historical High2.85Limit Down2.52%Amplitude2.21Historical Low--Dividend TTM3.17Avg Price114.80KlotAsk--Div YieldTTM100Lot Size76.19KlotBid
Zhejiang Yatai Pharmaceutical News
Asia Pacific Pharmaceutical: Announcement on participating in the 2025 Online Group Reception Day for Investors of Listed Companies in Zhejiang Province and the 2024 Annual Results Briefing
Asia Pacific Pharmaceutical: Announcement on the Company\'s Acyclovir for Injectable Acyclovir Passing the Conformity Evaluation of Generic Drugs
Asia Pacific Pharmaceutical: Internal Control Audit Report
Asia Pacific Pharmaceuticals: Announcement on Proposed Renewal of Accounting Firms
Asia Pacific Pharmaceutical: Special inspection opinions on the 2024 operating income deduction matters of Zhejiang Asia Pacific Pharmaceutical Co., Ltd.
Asia Pacific Pharmaceutical: Report on the Work of the Supervisory Committee 2024
Asia Pacific Pharmaceutical: 2024 Annual Audit Report
Asia Pacific Pharmaceutical: Special Instructions on the Use of Annual Funds Raised
Asia Pacific Pharmaceutical: Announcement of Supervisory Committee Resolutions
Asia Pacific Pharmaceutical: Annual Verification Report on the Use of Raised Funds
Asia Pacific Pharmaceuticals: Independent Director\'s Annual Debriefing Report
Asia Pacific Pharmaceuticals: Notice on Changes in Accounting Policies
Asia Pacific Pharmaceutical: Board\'s Special Opinion on Independent Directors\' Independence Assessment
Asia Pacific Pharmaceutical: Announcement on the Company\'s Application for a Comprehensive Credit Line from the Bank
Asia Pacific Pharmaceuticals: Articles of Association
Asia Pacific Pharmaceutical: Announcement of Board Resolutions
Asia Pacific Pharmaceutical: Annual Special Audit Report on Related Party Capital Occupation
Asia Pacific Pharmaceutical: Internal Control Self-Assessment Report
Asia Pacific Pharmaceutical: 2024 Independent Director\'s Debriefing Report (Cai Min)
Asia Pacific Pharmaceutical: 2024 Independent Director\'s Debriefing Report (Liu Yuehui)
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting